Category & trade
Primary
pharmaceutical-drugs · embed-ft 0.45
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Tech stack
AI readiness
AI-Readiness score
36 / 100 · partial · see similar
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
llms.txt ai.txt humans.txt robots.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
EMFLAZA® (deflazacort) | For Healthcare Professionals
Description
EMFLAZA® (deflazacort) is the first & only FDA-approved corticosteroid for boys with Duchenne muscular dystrophy as young as age 2. See efficacy and safety data and view full Prescribing Information & Important Safety Information.
Final URL
Language
en (html)
Scanned at
2026-07-05 14:15:16